Loading
BeyondSpring Inc. Stock: price and insider trades · United States
Insider Decl.
64
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€2M
63 ops. · all time
Who traded when
BuySaleDecheng Capital China Life Sciences USD Fund III, L.P.63 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.52
Analyst consensus
Income statement
EBITDA-US$8.9M
Net income-US$1M0.0% margin
Valuation
Beta-0.21
Balance sheet & cash
Market capUS$21.2M
Total debtUS$320k
Free Cash Flow-US$19.8M
Profitability & ownership
ROA-22.9%
% insiders17.4%
% institutions14.8%
Last declaration on 15 May 2026
Declarations64 total
260,582 shares0Ordinary SharesSEC:0001193125-26-226749:0
45,513 shares@ US$1.763.9% of flowOrdinary SharesSEC:0001231919-25-000335:1
85,798 shares@ US$1.7226.4% of flowOrdinary SharesSEC:0001231919-25-000335:0
28,495 shares@ US$1.652.3% of flowOrdinary SharesSEC:0001231919-25-000323:1
17,960 shares@ US$1.651.5% of flowOrdinary SharesSEC:0001231919-25-000323:2
107,361 shares@ US$1.7033.0% of flowOrdinary SharesSEC:0001231919-25-000323:0
3,979 shares@ US$1.810.4% of flowOrdinary SharesSEC:0001231919-25-000308:1
2,390 shares@ US$1.770.2% of flowOrdinary SharesSEC:0001231919-25-000308:2
7,507 shares@ US$1.772.4% of flowOrdinary SharesSEC:0001231919-25-000308:0
600 shares@ US$1.760.2% of flowOrdinary SharesSEC:0001231919-25-000292:0
17,500 shares@ US$1.785.6% of flowOrdinary SharesSEC:0001231919-25-000292:1
2,100 shares@ US$1.790.7% of flowOrdinary SharesSEC:0001231919-25-000292:2
2,601 shares@ US$1.800.2% of flowOrdinary SharesSEC:0001231919-25-000278:1
600 shares@ US$1.730.1% of flowOrdinary SharesSEC:0001231919-25-000278:2
4,464 shares@ US$1.811.4% of flowOrdinary SharesSEC:0001231919-25-000278:0
600 shares@ US$1.680.0% of flowOrdinary SharesSEC:0001231919-25-000258:1
500 shares@ US$1.750.0% of flowOrdinary SharesSEC:0001231919-25-000258:2
700 shares@ US$1.660.2% of flowOrdinary SharesSEC:0001231919-25-000258:0
4,106 shares@ US$1.720.3% of flowOrdinary SharesSEC:0001231919-25-000244:1
2,256 shares@ US$1.680.2% of flowOrdinary SharesSEC:0001231919-25-000244:2
5,410 shares@ US$1.831.8% of flowOrdinary SharesSEC:0001231919-25-000244:0
5,307 shares@ US$1.740.4% of flowOrdinary SharesSEC:0001231919-25-000221:1
3,656 shares@ US$1.790.3% of flowOrdinary SharesSEC:0001231919-25-000221:2
2,304 shares@ US$1.830.7% of flowOrdinary SharesSEC:0001231919-25-000221:0
700 shares@ US$1.850.2% of flowOrdinary SharesSEC:0001736814-25-000007:0
25 of 64 declarations
About BeyondSpring Inc.
Almost the whole BeyondSpring Inc. record comes from a single filer: Decheng Capital China Life Sciences USD Fund III, L.P., 10% Owner, signs 63 of the 64 filings, all sales, worth EUR 1.7 million in total with a median of EUR 4,227. The three largest took place in June 2025: EUR 618,170 on June 20, 2025, EUR 163,652 on June 18, 2025 and EUR 162,081 on June 20, 2025. The other filing is Lan Huang's, Chief Executive Officer, with no purchase or sale. No purchase appears. Transactions run from June 17, 2025 to March 20, 2026, with 63 filings for 2025 and 1 for 2026, published a median of 2 days after the trade. Only one filing falls in the last twelve months, as the whole record is recent. BeyondSpring is a US healthcare and pharma company with a market capitalisation of USD 21.2 million, of which 17.4% is held by insiders.
